Definitive Contract 75N99226C00001
Award Date 6/1/26
Potential Completion Date 11/30/28
Potential Value $18M
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Time and Materials
Place of Performance
Manchester, NH 03101, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
2
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Food and Drug Administration awarded Advanced Regenerative Manufacturing Institute Inc. (Armi), a non-profit organization based in Manchester, New Hampshire, a definitive contract valued at $2.24M for the Biofab Foundry initiative. This contract, awarded on September 19, 2024, represents an extension of the period of performance through September 29, 2027, with a modified technical approach and increased funding relative to the original award. The Biofab Foundry project focuses on developing...
- The Defense Health Agency awarded a $47,181.20 firm fixed price purchase order contract to Advanced Regenerative Manufacturing Institute Inc. (Armi), a non-profit organization focused on tissue engineering and regenerative medicine. The contract is for meeting room space, food/beverage, and audio-visual support for the U.S. Army Medical Research and Development Command's (USAMRDC) Fiscal Year 2025 Fall Strategic Offsite event in Manchester, New Hampshire. The requirements, which were...
- The National Institutes of Health has awarded a $600,000 firm fixed-price definitive contract to Halcyon Biomedical Inc., a small business based in Friendswood, Texas, to develop a point-of-care system for cell therapy manufacturing and delivery. The contract, awarded on March 2, 2026, with an ultimate completion date of September 1, 2027, emerged from the Advanced Research Projects Agency for Health's Fiscal Year 2024 Small Business Innovation Research (SBIR) program. This award is set aside...
- This is a $29,266,207.99 firm fixed price contract awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) to Advanced Regenerative Manufacturing Institute Inc. (Armi), a non-profit organization. The contract aims to establish the Foundry for American Biotechnology (NEXTFAB) to accelerate research, development, manufacturing, and deployment of revolutionary advances in science to support pandemic preparedness and...
- The Office of the Assistant Secretary for Preparedness and Response (civilian agency within the Department of Health and Human Services) awarded a definitive contract to Wake Forest University Health Sciences for development of human organ tissue equivalent models of fibrosing chemical exposure to bridge preclinical and clinical translation of medical countermeasures, with a ceiling value of $48.6 million and an ultimate completion date of January 31, 2033. The award, issued on September 21,...
- This is a $1,648,645.00 Firm Fixed Price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Cell Microsystems Inc. under the Small Business Innovation Research (SBIR) Phase II program. The purpose of this contract is to focus on developing a T-cell activation protocol consistent with reporter cell viability, creating a proprietary reporter cell line, and gathering and benchmarking...
- This is a $4,497,196.00 cost-plus-fixed-fee delivery order contract awarded by the National Institutes of Health (NIH) to The Mitre Corporation, a non-profit organization that operates federally funded research and development centers (FFRDCs). The contract is for strategic support services for the Advanced Research Projects Agency for Health (ARPA-H), a new agency established to accelerate the pace of health and medical breakthroughs. Mitre will provide a range of technical services,...
- This federal contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Revela Biotech LLC, a for-profit limited liability company. The contract, titled "TOPIC 396: NON-INVASIVE DETECTION OF HUMAN CD8+ T CELLS: A PET-BASED APPROACH TO ASSESS THE HUMAN IMMUNE SYSTEM - MOONSHOT", has a potential value of $298,685.00 and was awarded on September 11, 2019, with a completion date of September 15, 2020. The...
- The Office of the Assistant Secretary for Preparedness and Response awarded a $61.98 million definitive contract to The Charles Stark Draper Laboratory, Inc. for development of a medical countermeasure evaluation platform on September 29, 2023, with an ultimate completion date of September 28, 2028. The contract carries no set-aside and uses cost-plus-fixed-fee pricing. The platform consists of vascular-immune and small intestine-immune organ-on-chip models, molecular assays, omics-based...
- This contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to the Southern Research Institute, a corporate entity tax-exempt non-profit organization. The contract is a Delivery Order under the In Vitro Assessments of Antimicrobial Activity (IVAAA) Indefinite Delivery/Indefinite Quantity (ID/IQ) contract vehicle. The $1,275,123.00 cost-plus-fixed-fee contract is for evaluating therapeutic product...